LipoScience downsizes

In an effort to manage its costs and streamline its operations, nano cap LipoScience (LPDX) terminates its contract with Health Diagnostic Laboratory and cuts 22 jobs.

Consensus revenue estimates for Q1 and 2014 are $12M and $48M, respectively.

23 mutual funds have positions, down from 41 a year earlier.

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs